Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Dan Vigneron, the head of the Surbeck Laboratory for Advanced Imaging at the University of California, San Francisco (UCSF) will give a talk on their clinical studies using hyperpolarized MRI in cancer patients (especially prostate cancer patients).

The group at UCSF were the first to undertake clinical studies with hyperpolarized 13C MRI and they have made some great advances in the development of novel imaging approaches for 13C MRI.